SIGNA Artist Evo

GE Healthcare(Tianjin) Company Limited · K213603 · 2022-02-11

SIGNA Artist Evo is an AI-enabled medical device from GE Healthcare(Tianjin) Company Limited, listed by FDA (510(k), K213603) with a decision date of 2022-02-11. Review panel: Radiology.

FDA submission numberK213603
Pathway510(k)
CompanyGE Healthcare(Tianjin) Company Limited
Review panel (specialty)Radiology
FDA decision date2022-02-11
DecisionSubstantially Equivalent
Product codeLNH
ClassificationSystem, Nuclear Magnetic Resonance Imaging
Device class2
Regulation number892.1000
Review time (calendar days)88
Applicant countryCN

Official FDA database record · FDA AI-enabled device list

More devices from GE Healthcare(Tianjin) Company Limited · All Radiology AI devices · Full device index

Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.